Moberg Pharma says wins patent approvals for MOB-015
Wednesday, May 18, 2016
Moberg Pharma announces multiple patent approvals for MOB-015 the Company's investigational topical treatment for onychomycosis (nail fungus).
Patents have been granted and Notice of Allowances received in multiple territories worldwide.
Says patent portfolio now includes 12 issued patents and 27 pending patent applications worldwide in four different patent families.
Source : reuters.com
